|
Q1 2019
Filed on May 15, 2019
|
556,904
|
$5.9 - $8.1
$3.29M - $4.51M
|
|
|
Q1 2019
Filed on May 15, 2019
|
4,600,000
|
N/A
|
|
|
Q1 2019
Filed on May 15, 2019
|
542,944
|
$2.95 - $3.64
$1.6M - $1.98M
|
|
|
Q1 2019
Filed on May 15, 2019
|
400,000
|
N/A
|
|
Assertio Therapeutics Inc
|
Q1 2019
Filed on May 15, 2019
|
3,278,000
|
N/A
|
|
|
Q1 2019
Filed on May 15, 2019
|
1,488,000
|
$5.1 - $6.71
$7.59M - $9.98M
|
|
Onconova Therapeutics Inc
|
Q1 2019
Filed on May 15, 2019
|
29,216
|
N/A
|
|
|
Q1 2019
Filed on May 15, 2019
|
332,000
|
$7.19 - $32.37
$2.39M - $10.7M
|
|
|
Q1 2019
Filed on May 15, 2019
|
1,723,254
|
N/A
|
|
|
Q1 2019
Filed on May 15, 2019
|
590,000
|
N/A
|
|
Titan Pharmaceuticals Inc De
|
Q4 2018
Filed on Feb 14, 2019
|
220,000
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
2,164,000
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
824,000
|
$31.91 - $45.65
$26.3M - $37.6M
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
900,000
|
$18.45 - $24.52
$16.6M - $22.1M
|
|
Novelion Therapeutics Inc
|
Q4 2018
Filed on Feb 14, 2019
|
1,856,000
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
900,000
|
$15.13 - $26.74
$13.6M - $24.1M
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
1,800,000
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
532,000
|
$22.42 - $32.67
$11.9M - $17.4M
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
658,000
|
$13.35 - $20.11
$8.78M - $13.2M
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
300,000
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
24,000
|
$114.93 - $220.1
$2.76M - $5.28M
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
536,000
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
2,300,000
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
100,000
|
$20.66 - $25.77
$2.07M - $2.58M
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
3,000,000
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
1,000,000
|
$22.38 - $33.92
$22.4M - $33.9M
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
1,000,000
|
$15.49 - $27.26
$15.5M - $27.3M
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
860,000
|
$0.21 - $2.55
$181K - $2.19M
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
1,564,000
|
$11.55 - $17.07
$18.1M - $26.7M
|
|
Biodelivery Sciences Intl In
|
Q4 2018
Filed on Feb 14, 2019
|
3,292,000
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
1,100,000
|
$42.25 - $52.49
$46.5M - $57.7M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
750,000
|
$38.94 - $53.67
$29.2M - $40.3M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
1,000,000
|
$27.9 - $38.05
$27.9M - $38.1M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
1,177,900
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
593,321
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
1,180,000
|
$22.83 - $32.67
$26.9M - $38.6M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
200,000
|
$36.88 - $52.07
$7.38M - $10.4M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
280,000
|
N/A
|
|
Catabasis Pharmaceuticals In
|
Q3 2018
Filed on Nov 14, 2018
|
2,000,000
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
500,000
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
1,576,000
|
$21.04 - $32.41
$33.2M - $51.1M
|
|
Onconova Therapeutics Inc
|
Q3 2018
Filed on Nov 14, 2018
|
1,688,235
|
N/A
|
|
Intellipharmaceutics Intl In
|
Q3 2018
Filed on Nov 14, 2018
|
8,600,000
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
497,044
|
N/A
|
|
Actinium Pharmaceuticals Inc
|
Q2 2018
Filed on Aug 14, 2018
|
6,100,000
|
N/A
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
4,300,000
|
N/A
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
3,592,000
|
N/A
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
88,000
|
N/A
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
1,000,000
|
N/A
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
1,836,000
|
$5.89 - $7.78
$10.8M - $14.3M
|
|